The COS-PP toolkit is intended to provide guidance and support for research related to psychiatric pharmacist impact. Students, residents, pharmacists, and faculty can use the COS-PP to help design clinical trials. Utilization of a unified core outcome set will ultimately benefit the patients by providing robust evidence of the value of having psychiatric pharmacists on the team to improve access to care, quality of care, and patient satisfaction.
Carla Cobb, PharmD, BCPP
This toolkit provides a resource for recognizing, understanding, and managing episodes of agitation and forms of aggression encountered in clinical practice. Various assessment tools and nonpharmacologic and pharmacologic interventions are reviewed as a means to improve outcomes and safety.
As a psychiatric pharmacist, you work every day to move things forward-patients, families, colleagues, students, your health care system. You move us forward too—as members, volunteers, mentors, thought leaders, and innovators. Your forward motion inspires ours as we work together at AAPP and AAPP Foundation to move psychiatric pharmacy forward, together in the following ways.
Psychiatric pharmacy continues to grow and look to the future with a focus on helping individuals recover from mental health and substance use disorders. The American Association of Psychiatric Pharmacists (AAPP) considers Board Certified Psychiatric Pharmacist (BCPP) the gold standard credential that all psychiatric pharmacists should attain to demonstrate specialized knowledge and expertise in psychiatry.
The nation’s drug overdose epidemic continues to change and become worse. The epidemic affects every state and now is driven by illicit fentanyl, fentanyl analogs, methamphetamine, and cocaine, often in combination or in adulterated forms. More than 107,000 deaths were reported in the United States between December 2020 to December 2021.
This mosaic was populated and revealed during CPNP 2022 in San Antonio, Texas by Annual Meeting attendees. Thank you to the CPNP/AAPP Foundation for co-sponsoring this experience!
Dr. Brittany Vickery is a psychiatric pharmacist working for Advent Health, a community hospital. Find out how her 800+ interventions each year helps patients transition back to home or assisted living facilities as soon and safely as possible.
Dr. Danielle Stutzman is a psychiatric pharmacist working for the Children’s Hospital Colorado Pediatric Mental Health Institute. Find out how her work providing medication education and caring for children in various practice settings is making a difference.
Dr. Jennifer Nelson is a psychiatric pharmacist working for one of the nation’s largest correctional systems, Dallas County Jail. Find out how her work managing psychiatric medications for pregnant inmates is highly valued by the medical team and obstetrician.
Dr. Rachel Bauer is a psychiatric pharmacist working for the George E. Wahlen Veterans Affairs (VA) Medical Center to help patients stay out of the hospital after an admission. Find out how her work coordinating transitions of care is reducing hospitals readmissions.
A 2019 survey identified significant variability of practice characteristics among outpatient psychiatric pharmacists (OPPs), including prescriptive authority. In response to this variability, AAPP launched a project to build consensus and develop practice model statements for psychiatric pharmacists providing direct care in an outpatient setting.
Cindy Gutierrez, PharmD, BCPP CPNP/AAPP President-Elect Associate Chief, Clinical Pharmacy Programs South Texas Veterans Health Care System
Psychiatric pharmacy continues to grow and look to the future with a focus on helping individuals recover from mental health and substance use disorders.
Rosana Steavenson, PharmD, BCPS, BCPP Program Manager, Mental Health Clinical Pharmacy Programs; Mental Health Clinical Pharmacy Practitioner South Texas Veterans Health Care System San Antonio, TX Chair, Theory to Practice Case Editorial Board
Carla Cobb, PharmD, BCPP Psychiatric Pharmacist Capita Consulting Billings, MT
Glen L. Stimmel, PharmD Professor Emeritus of Clinical Pharmacy, Psychiatry and the Behavioral Sciences Titus Family Department of Clinical Pharmacy University of Southern California Los Angeles, CA CPNP Past President
Julie Dopheide, PharmD, BCPP Professor of Clinical Pharmacy, Psychiatry and Behavioral Sciences University of Southern California Los Angeles, CA CPNP Commission on Innovation and Advancement Committee Member
This style guide has been created to encourage a consistent voice and message across all initiatives regardless of audience. Notes have been added when the context (e.g., patient resources) matters.
The studies identified below are part of a systematic review that is pending publication. Methods, additional study details, and meta-analysis will be included in that publication. The table below indicates which types of outcomes were collected in each study.
New Name, Same Organization. From the College of Psychiatric and Neurologic Pharmacists (CPNP) to the American Association of Psychiatric Pharmacists (AAPP)